title: Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
abstract: Combination lovastatin and probucol reduced total cholesterol (27%) and low-density lipoprotein levels (30%), but did not prevent restenosis or clinical events during the first 6 months after percutaneous transluminal coronary angioplasty.
authors.affiliation: Mid America Heart Institute, St. Luke's Hospital, Kansas City, Missouri, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: O'Keefe
authors.forename: G W
authors.initials: GW
authors.lastname: Stone
authors.forename: B D
authors.initials: BD
authors.lastname: McCallister
authors.forename: C
authors.initials: C
authors.lastname: Maddex
authors.forename: R
authors.initials: R
authors.lastname: Ligon
authors.forename: R L
authors.initials: RL
authors.lastname: Kacich
authors.forename: J
authors.initials: J
authors.lastname: Kahn
authors.forename: P G
authors.initials: PG
authors.lastname: Cavero
authors.forename: G O
authors.initials: GO
authors.lastname: Hartzler
authors.forename: B D
authors.initials: BD
authors.lastname: McCallister
mesh_terms: D000328:Adult; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003251:Constriction, Pathologic; D003327:Coronary Disease / Q000097:blood / Q000601:surgery*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008148:Lovastatin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011341:Probucol / Q000627:therapeutic use*; D012008:Recurrence
chemical_list: D000924:Anticholesteremic Agents; D008074:Lipoproteins; D008148:Lovastatin; D011341:Probucol